Serum hepatocyte growth factor and interleukin-6 levels can distinguish patients with primary or metastatic liver tumors from those with benign liver lesions

Neoplasma

Volumn 51, Issue 3, 2004, Pages 209-213

  Coskun, U ^a   Bukan, N ^a   Sancak, B ^a   Gunel N ^a   Ozenirler, S ^a   Unal, A ^a   Yucel, A ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Hepatocellular carcinoma; Hepatocyte growth factor; Interleukin 6; Liver tumors

Indexed keywords

INTERLEUKIN 6; SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; ANGIOGENESIS; ARTICLE; AUTOCRINE EFFECT; BENIGN TUMOR; BREAST CANCER; CANCER PATIENT; CANCER REGRESSION; CONTROLLED STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER TUMOR; MAJOR CLINICAL STUDY; PARACRINE SIGNALING; TUMOR CELL;

EID: 3042575159     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. BARROS EJ, SANTOS OF, MATSUMOTO K, NAKAMURA T, NI GAM SK. Differential tubulogenic and branching morphogenic activities of growth factors: implications for epithelial tissue development. Proc Natl Acad Sci USA 1995; 92: 4412-4416.
2. BLAY JY, NEGRIER S, COMBARET V, ATTALI S, GOILLOT E et al. Serum level of interleukin-6 as a prognosis factor in metastatic renal cell carcinoma. Cancer Res 1992; 52: 3317-3322.
3. BORSET M, HJORTH-HANSEN H, SEIDEL C, SUNDAN A, WAAGE A. Hepatocyte growth factor and its receptor c-met in multiple myeloma. Blood 1996; 88: 3998-4004.
4. BRINKMANN V, FOROUTAN H, SACHS M, WEIDNER KM, BIRCHMEIER W. Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells. J Cell Biol 1995: 131: 1573-1586.
5. BURR AW, HILLAN KJ, McLAUGHLIN KE, FERRIER R, CHAPMAN C et al. Hepatocyte growth factor levels in liver and serum increase during chemical hepatocarcinogenesis, Hepatology 1996; 24: 1282-1287.
6. BUSSOLINO F, DI RENZO MF, ZICHE M, BOCHIETTO E, OLIVERO M et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992; 199: 629-641.
7. CHAU GY, WU CW, LUI WY, CHANG TJ, KAO HL et al. Serum interleukin-10 but not interleukin-6 is related to clinical outcome in patient with resectable hepatocellular carcinoma. Ann Surg 2000; 231: 552-558.
8. DE JONG KP, VAN GAMEREN MM, BIJZET J, LIMBURG PC, SLUITER WJ et al. Recombinant human interleukin-6 induces hepatocyte growth factor production in cancer patients. Scand J Gastroenterol 2001; 36: 636-640.
9. DIVIERE J, CONTENT J, DENYS C. High Interleukin-6 serum levels and increase production by leukocytes in alcoholic liver cirrhosis: correlation with IgA serum levels an lymphokine production. Clin Exp Immunol 1989; 77: 221-225.
10. FUKURA T, MIKI C, INOUE T, MATSUMOTO K, SUZIKI H. Serum hepatocyte growth factor as an index of disease status of patients with colorectal carcinoma. Br J Cancer 1998; 78: 454-459.
11. GHERARDI E, GRAY J, STOKER M, PERRYMAN M, FURLONG R. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movements. Proc Natl acad USA 1989; 86: 5844-5848.
12. GRANT DS, KLEINMAN JL, GOLDBERG ID, BHARGAVA MM, NICKOLOFF BJ et al. Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993; 90: 1937-1941.
13. HIRANO T, MATSUDA T, TURNER M, MIYASAKA N, BUCHAN G et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumotoid arthritis. Eur J Immunol 1988; 18: 1797-1801.
14. HO RT, LIEW CT, LAI KN. The expression of hepatocyte growth factor and interleukin 6 (IL-6) in damaged human liver and kidney tissues. Hepato-Gastroenterol 1999; 46: 1904-1909.
15. HORII Y, MURAGUCHI A, IWANO M, MATSUDA T, HIRAYAMA T et al, Involvement of IL-6 in mesengial proliferative glomerulonephritis. J Immunol, 1989; 143: 3949-3955.
16. ISHIKO T, MITA S, SAKAMOTO K, OGAWA M. Fibroblast-tumor interaction changes constitutive expression of IL-6 and IL-8 in human carcinoma cells. Int J Oncol 1995; 6: 639-645.
17. IWASASI T, HAMANO T, OGATA A, HASHIMOTO N, KITANO M, KAKISHITA E. Clinical significance of vascular endothelial growth factor and hepatocyte growth factor in multiple myeloma. Br J Haematol 2002; 116: 796-802.
18. KAWAIDA K, MATSUMOTO K, SHIMAZU H, NAKAMURA T. Hepatocyte growth factor prevents acute renal failure and accelerates renal cell regeneration in mice. Proc Natl Acad Sci USA 1994; 91: 4357-4361.
19. MAEMURA M, IINO Y, YOKOE T, HORIGUCHI J, TAKEI H et al. Serum concentration of hepatocyte growth factor in patients with metastatic breast cancer. Cancer Lett 1998; 126: 215-220.
20. MICHALOPOULOS GK, DEFRANCES MC. Liver regeneration. Science 1997; 276: 60-66.
21. MONTESANO T, MATSUMOTO K, NAKAMURA T. Identification of a fibroblast-derived epithelial morphogen as hepatocyte growth factor. Nature 1989; 342: 440-443.
22. MONTESANO R, MATSUMOTO K, NAKAMURA T, ORCI L, Identification of a fibroblast derived ephithelial morphogen as hepatocyte growth factor. Cell 1991; 67: 901-908.
23. OHIRA H, MIYATA M, KURODA M, TAKAGI T, TOJO J et al. Interleukin-6 induces proliferation of rat hepatocytes in vivo. J Hepatol 1996; 25: 941-947.
24. ROSEN EM, KNESEL J, GOLDBERG ID, JIN L, BHARGAVA M et al. Scatter factor modulates the metastatic phenotype of EMT6 mouse mamary tumor. Int J Cancer 1994; 57: 706-714.
25. RUBIN JS, CHAN AM, BOTTARO DP, BURGESS WH, TAYLOR WG et al. A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor. Proc Natl acad USA 1991; 88: 415-419.
26. SATO T, HAKEDA Y, YAMAGUCHI Y, MANO H, TEZUKA K et al. Hepatocyte growth factor is involved in formation of osteoclast-like cells mediated by clonal stromal cells (MC3T3-G2/PA6). J Cell Physiol 1995; 164: 197-204.
27. SCAMBIA G, TESTA U, PANICI PB, MARTUCCI R, FOTI E et al. Interleukin-6 serum levels in patients with gynecological tumors. Int J Cancer 1994; 57: 318-323.
28. SHIOTA G, OKANO J, KAWASAKI H, KAWAMOTO T, NAKAMURA T. Serum hepatocyte growth factor levels in liver disease: clinical implications. Hepatology 1995; 21: 106-112.
29. SIEGAL CB, SCHWAB G, NORDAN RP. Expression of interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res 1990; 50; 7784-7788.
30. SINGH-KAW P, ZARNEGAR R, SIEGFRIED JM. Stimulatory effects of hepatocyte growth factor on normal and neoplastic human epithelial cells. Am J Physiol 1995; 288: 1012-1020.
31. SRIVASTAVA M, ZURAKOWSKI D, CHEIFETZ P, LEICHTNER A, BOUSVAROS A. Elevated serum hepatocyte growth factor in children and young adults with inflammatory bowel disease. J Pediatr Gastr Nutr 2001; 33: 548-553.
32. TABIBZADEH SS, POUBOURIDIS D, MAY LT, SEHGAL PB. Interleukin 6 immunoreactivity in human tumors. Am J Pathol 1989; 135: 427-433.
33. TAKADA N, YANO Y, MATSUDA T, OTANI S, OSUGI H et al. Expression of immune reactive hepatocyte growth factor in human esophageal squamous cell carcinomas. Cancer Lett 1995; 97: 145-148.
34. VAN MEIR EV, SAWAMURA Y, DISERENS AC, HAMOU MF, DE TRIBOLET N. Human glioblastoma cells release interleukin 6 in vivo and in vitro. Cancer Res 1990; 50: 6683-6688.
35. WATSON JM, SENSINTAFFAR JL, BEREK JS, MARTINEZ-MAZA O. Constitutive production of interleukin 6 by ovarian cancer cell-lines and by primary ovarian tumor cultures. Cancer Res 1990; 50: 6959-6965.
36. WEINDER KM, BEHRENS J, VANDEKERCKHOVE J, BIRCHMEER W. Scatter factor: molecular charecteristics and effects on the invasiveness of epithelial cells. J Cell Biol 1990; 111: 2097-2108.
37. YAMASHITA J, OGAWA M, YAMASHITA S, NOMURA K, KURAMOTO M et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Research 1994; 54: 1630-1633.
38. YANAGITA K, MATSUMOTO K, SEKIGUCHI K, ISHIBASHI H, NIHO Y, NAKAMURA T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-21217.
39. YOSHINAGA Y, MATSUNO Y, FUJITA S, NAKAMURA T, KIKUCHI M et al. Immunohistochemical detection of hepatocyte growth factor/scatter factor in human cancerous and inflamatory lesions of various organs. Jpn J Cancer Res 1993; 84: 1150-1158.
40. ZARNEGAR R, MICHALOPOULOS GK. The many faces of hepatocyte growth factor: from hepatopoesis to hematopoesis. J Cell Biol 1995; 129: 1177-1180.
41. ZHANG G-J, ADACHI I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anti Cancer Res 1999; 19: 1427-1432.